Bibliometric Analysis of Renal Fibrosis in Diabetic Kidney Disease From 1985 to 2020

被引:16
|
作者
Zhang, Yuqing [1 ]
Jin, De [1 ]
Duan, Yingying [2 ]
Zhang, Yuehong [1 ]
Duan, Liyun [1 ]
Lian, Fengmei [1 ]
Tong, Xiaolin [3 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Guanganmen Hosp, Endocrinol Dept, Beijing, Beijing, Peoples R China
[3] Changchun Univ Chinese Med, Endocrinol Dept, Affiliated Hosp, Changchun, Peoples R China
关键词
bibliometrics; diabetic kidney disease; renal fibrosis; CiteSpace; cluster analysis; NEPHROPATHY; MECHANISMS; ORIGIN; MYOFIBROBLAST; ACTIVATION; TRANSITION; EVENTS; AXIS;
D O I
10.3389/fpubh.2022.767591
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundDiabetic renal fibrosis (DRF) is an irreversible renal pathological change in the end-stage of diabetic kidney disease (DKD), which plays a significant role in the development and deterioration of the disease. However, data for bibliometric analysis of renal fibrosis in DKD is currently missing. This study aimed to provide a comprehensive and visualized view of DRF research and lay the foundation for further studies. Materials and MethodsFirstly, the data was collected from the Web of Science Core Collection (WoSCC) database. Secondly, the Web of Science analytic tool was performed to analyze publication years, authors, countries/regions, organizations, and citation frequency. Finally, CiteSpace was employed to construct a visualization bibliometric network to reveal the emerging trends and hotspots of DRF. ResultsA total of 3,821 publications from 1985 to 2020 were included in this study. The number of publications has maintained a growth trend since 2003. Cooper is the most prolific author in this field, and the American Journal of Physiology-Renal Physiology ranking as first place compared with other journals. In terms of the number of publications, China contributed the most to DRF. Monash University is the organization that published the most papers. The top 5 clusters of keyword co-appearance are "chronic kidney disease", "primary biliary cirrhosis", "receptor", "TGF-beta", "renal tubulointerstitium". The top 5 clusters of reference co-citation are "microRNAs", "bone morphogenetic protein", "hypertrophy", "glomerulosclerosis", "diabetic kidney disease". The strongest citation burst of keyword is "diabetic kidney disease" and the strongest burst of cited reference is "Meng, 2016". ConclusionsThe present study analyzed the research hotspots, Frontiers, and development trend of DRF and have important implications for future research.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Focus on podocytes: diabetic kidney disease and renal fibrosis - a global bibliometric analysis (2000-2024)
    An, Dong-Yang
    Tan, Jun
    Lu, Yan-Dan
    Wen, Ze-Huai
    Bao, Yi-Ni
    Yao, Zhou-Hui
    Chen, Zi-Yan
    Wang, Ping-Ping
    Zhou, Wei
    Yang, Qiao
    Hao, Min
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [2] Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
    Sakuma, Hiroko
    Hagiwara, Shinji
    Kantharidis, Phillip
    Gohda, Tomohito
    Suzuki, Yusuke
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [3] Global diabetic kidney disease research from 2000 to 2017: A bibliometric analysis
    Zou, Lu-Xi
    Sun, Ling
    MEDICINE, 2019, 98 (06)
  • [4] Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
    Wang, Mei-Zi
    Wang, Jie
    Cao, Dong-Wei
    Tu, Yue
    Liu, Bu-Hui
    Yuan, Can-Can
    Li, Huan
    Fang, Qi-Jun
    Chen, Jia-Xin
    Fu, Yan
    Wan, Bing-Ying
    Wan, Zi-Yue
    Wan, Yi-Gang
    Wu, Guo-Wen
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2
    Xia, Yang
    Jiang, Hongwei
    Chen, Jinwen
    Xu, Fang
    Zhang, Guoxiu
    Zhang, Dongshan
    LIFE SCIENCES, 2023, 320
  • [6] Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease
    Fang, Qing
    Zheng, Binjie
    Liu, Na
    Liu, Jinfeng
    Liu, Wenhui
    Huang, Xinyi
    Zeng, Xiangchang
    Chen, Lulu
    Li, Zhenyu
    Ouyang, Dongsheng
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [7] Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease
    Hu, Hongtu
    Li, Weiwei
    Hao, Yiqun
    Peng, Zhuan
    Zou, Zhengping
    Liang, Wei
    PHYTOMEDICINE, 2024, 122
  • [8] Associations between local acidosis induced by renal LDHA and renal fibrosis and mitochondrial abnormalities in patients with diabetic kidney disease
    Lee, Dae-Yeon
    Kim, Ji-Yeon
    Ahn, Eunyong
    Hyeon, Jin Seong
    Kim, Gyu-Hee
    Park, Keon-Jae
    Jung, Youngae
    Lee, Yoo-Jeong
    Son, Mi Kyoung
    Kim, Seung Woo
    Han, Sang Youb
    Kim, Jae-Hong
    Roh, Gu Seob
    Cha, Dae Ryong
    Hwang, Geum-Sook
    Kim, Won-Ho
    TRANSLATIONAL RESEARCH, 2022, 249 : 88 - 109
  • [9] Impact of baicalin and components of Scutellaria baicalensis on renal fibrosis of diabetic kidney disease
    Li, Jiarui
    Zhuang, Yuan
    Fan, Guoyong
    Wang, Simeng
    Yan, Enhui
    Guo, Jianpeng
    Zhang, Chi
    Jiang, Shicui
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] The intellectual base and global trends in inflammation of diabetic kidney disease: a bibliometric analysis
    Shi, LuYao
    Li, ChangYan
    Wang, Jian
    Zhong, HuaChen
    Wei, Tao
    Fan, WenXing
    Li, Zhen
    RENAL FAILURE, 2023, 45 (02)